Consolidated Statements of Operations (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Consolidated Statements Of Operations
Revenue	$ 1,837	$ 16,710	$ 7,811	$ 16,710
Costs of revenues
Amortization of patents	133,785		133,785
Compensation and compensation related expenses (including stock based compensation)	6,392,503		7,129,025
Research and development expense	9,648	107,817	9,648	617,469
Professional fees	2,139,977		2,867,945
Rent	60,433		132,475
Depreciation expense	2,519		24,009
Other selling, general and administrative	579,740	542,538	884,858	1,765,721
Total operating expenses	9,318,605	650,355	11,181,745	2,383,190
Operating loss	(9,316,768)	(633,645)	(11,173,934)	(2,366,480)
Loss from operations
Interest income	202	830	739	2,774
Fair value adjustments for warrant liabilities	36,583	58,413	(2,610,465)	740,605
Loss from continuing operations before taxes	(9,279,983)	(574,402)	(13,783,660)	(1,623,101)
Income tax expense
Loss from continuing operations	(9,279,983)	(574,402)	(13,783,660)	(1,623,101)
Discontinued operations
Loss from discontinued operations before taxes		(133,148)		(323,423)
Income tax expense
Loss from discontinued operations		(133,148)		(323,423)
Net loss	$ (9,279,983)	$ (707,550)	$ (13,783,660)	$ (1,946,524)
Net loss per share, basic and diluted
Continuing operations	$ (6.93)	$ (2.76)	$ (14.43)	$ (8.09)
Discontinued operations		$ (0.64)		$ (1.61)
Net loss per share, basic and diluted	$ (6.93)	$ (3.40)	$ (14.43)	$ (9.70)
Weighted average number of shares outstanding, basic and diluted	1,339,300	207,806	955,292	200,547